Company
Phio Pharmaceuticals Corp.
PHIO · CIK 0001533040
SEC FORM 4CLUSTER · 2 INSIDERS
$8,640.35
Purchase of 8,500 shares across 2 reporting persons.
Transaction Code P · Reporting Persons 2
- Bitterman Robert J, Chairman, Pres. & CEOPurchase of 2,000 shares at $1.0289 per share.$2,057.80
- BRADFORD PATRICIA APurchase of 6,500 shares at $1.0127 per share.$6,582.55
Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Sep 22, 2026 · Disclosed Sep 25, 2026FILED +3 DAYS
Source: SEC Form 4 · 0001683168-26-007321 · filed 2026-09-23 · View filing →
Source: SEC Form 4 · 0001683168-26-007432 · filed 2026-09-25 · View filing →
Permalink →
Purchase of 12,000 shares at $1.03 per share.
Reporting Person BRADFORD PATRICIA A · Transaction Code P
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001683168-26-007192 · filed 2026-09-16 · View filing →
Disposition (code F) of 12,888 shares at $1.03 per share.
Reporting Person Carson Lisa Cabott · Officer Title Chief Financial Officer · Transaction Code F
Traded Sep 11, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001683168-26-007158 · filed 2026-09-15 · View filing →
Disposition (code F) of 68,550 shares at $1.03 per share.
Reporting Person Bitterman Robert J · Officer Title Chairman, Pres. & CEO · Transaction Code F
Traded Sep 11, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001683168-26-007159 · filed 2026-09-15 · View filing →
SEC FORM 4CLUSTER · 2 INSIDERS
$27,700.00
Purchase of 25,000 shares across 2 reporting persons.
Transaction Code P · Reporting Persons 2
- Bitterman Robert J, Chairman, Pres. & CEOPurchase of 10,000 shares at $1.06 per share.$10,600.00
- Plott Ronald ToddPurchase of 15,000 shares at $1.14 per share.$17,100.00
Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001683168-26-006592 · filed 2026-08-19 · View filing →
Source: SEC Form 4 · 0001683168-26-006620 · filed 2026-08-20 · View filing →
Permalink →